(Q35095393)

6 August 2017

1 reference

title

Targeting gene therapy vectors to the vascular endothelium (English)

1 reference

6 August 2017

0 references

0 references

Lorraine M Work

1

0 references

Stuart A Nicklin

object named as

Stuart A Nicklin

series ordinal

2

0 references

author name string

Andrew H Baker

series ordinal

3

1 reference

6 August 2017

1 May 2003

1 reference

Current Atherosclerosis Reports

6 August 2017

1 reference

6 August 2017

5

1 reference

6 August 2017

3

1 reference

6 August 2017

163-170

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-003-0019-9

6 August 2017

0 references

cites work

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Vasoprotection by nitric oxide: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Gene transfer into vascular cells using adeno-associated virus (AAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Use of phage display to identify novel peptides for targeted gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Steps toward mapping the human vasculature by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Targeting the prostate for destruction through a vascular address

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Improved adenovirus vectors for infection of cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Targeting of high-capacity adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0019-9

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

21 January 2018

1 reference

12 December 2020

Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo

1 reference

12 December 2020

Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium

1 reference

12 December 2020

Gene Therapy for Cardiovascular Disease

1 reference

12 December 2020

Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C.

1 reference

12 December 2020

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

12 December 2020

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

1 reference

12 December 2020

Adeno-associated virus vectors for vascular gene delivery

1 reference

12 December 2020

Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob

1 reference

12 December 2020

10.1007/S11883-003-0019-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12667427